Log in

GRANULES Granules India Limited NSE · India

Granules India (GRANULES) news

Granules India Limited is a public biotech or pharmaceutical company listed on NSE under the ticker GRANULES, recorded under India. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Granules India news

We have not published a story on Granules India yet. When there is news, it will appear here.

Questions about Granules India

What is the ticker symbol of Granules India?

Granules India Limited trades under the ticker GRANULES on NSE.

Where is Granules India listed?

Granules India Limited is listed on NSE. Our directory also records these other listings: BSE:GRANULES.

Which country or territory is Granules India listed under?

Our directory records Granules India Limited under India.

What does Granules India do?

Our directory classifies Granules India Limited as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Granules India?

The ISIN recorded for Granules India Limited is INE101D01020.

Does aibio.space cover Granules India?

aibio.space lists Granules India Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Granules India?

Companies in our directory listed in the same country and business area as Granules India: Lyka Labs, Valiant Laboratories, Coral Laboratories, Sandu Pharmaceuticals, Rubicon Research, Alkem Laboratories.

Investor discussion: Granules India

Members talk about Granules India (GRANULES). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:GRANULES on TradingView.

Listing details

Granules India Limited is a public biotech or pharmaceutical company listed on NSE under the ticker GRANULES, recorded under India. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Granules India Limited
Ticker
GRANULES
Listing
NSE
Country or territory
India
Business scope
Biopharma / pharmaceutical profile checked
ISIN
INE101D01020
Other listed symbols
BSE:GRANULES
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.